Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The FDA has given emergency approval for an at-home test for both COVID-19 and the flu.
Pfizer now plans to ship 50 million COVID-19 vaccine doses by the end of this year, half of its original estimate of 100 million doses, The Wall Street Journal reported.
A shortage of lab workers to process diagnostic tests is the biggest obstacle to the U.S. increasing its testing capacity, experts told The New York Times.
Walmart and Sam's Club will begin selling at-home COVID-19 tests online this week, the company said Dec. 3.
Ten hospitals and health systems posted job listings for supply chain expertise in the last week:
Studies show that some rapid COVID-19 tests don't perform as well in children as they do in adults, meaning low-level infections in youth may go undetected, The New York Times reported.
The U.S. Department of Transportation has approved new rules allowing for the fast shipment of COVID-19 vaccines in preparation for authorization from the FDA.
Roche has received emergency approval from the FDA for a new COVID-19 antibody test that detects antibodies against the coronavirus' spike protein and could be used to gauge people's immune responses to COVID-19 vaccines.
One-third of states said they are "greatly" or "completely" worried they won't have enough supplies to administer COVID-19 vaccines when they are approved, according to a report released Nov. 30 by the U.S. Government Accountability Office.
United Airlines carried the first mass air shipment of COVID-19 vaccines last week from Brussels to Chicago, CNBC reported.